Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex

被引:28
作者
ONeill, CF
Ormerod, MG
Robertson, D
Titley, JC
CumberWalsweer, Y
Kelland, LR
机构
[1] Cancer Res. Campaign Ctr. Cancer T., Institute of Cancer Research, Sutton, Surrey SM2 5NG
关键词
apoptosis; cis/trans platinum analogues;
D O I
10.1038/bjc.1996.486
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), initiate apoptosis in this cell line at physiologically relevant concentrations (IC50 values 2 h drug exposure were 35.3 mu M for JM149 and 18.7 mu M for JM335). While at equimolar drug concentrations there was a 2-fold higher level of total platinum-DNA adducts following exposure to JM335 vs JM149, at equitoxic concentrations, levels were similar (80 vs 70 pmol Pt mg(-1) DNA respectively). Following a 2 h incubation with 2xIC(50) Of both drugs, cells rounded up and detached in a time-dependent manner but with the kinetics of apoptosis being more rapid for JM335. The majority of detached cells exhibited morphology associated with apoptosis which was further supported by the presence of a 50 kb fragment detected in DNA lysates prepared from these cells. JM149 induced apoptosis across a range of Concentrations (2x, 5x and 10xIC(50)) with a 50 kb DNA fragment being detected at all concentrations. However, in marked contrast to this, JM335 failed to cause apoptosis at 10xIC(50), the detached cells neither displaying apoptotic morphology nor a detectable 50 kb DNA fragment. Moreover, these detached cells showed evidence of extensive vesiculation while the DNA remained normal in appearance and thus appeared to have died by a non-apoptotic mode. Apoptosis also appeared to be induced to a lesser extent at 5xIC(50) Of JM335 as demonstrated by a less intense 50 kb fragment compared with that seen at 2xIC(50). The main cell cycle effect of these drugs (at 2xIC(50)) was a slowdown in S-phase traverse during which most but not all of the apoptosis appeared to occur. However, at 5xIC(50) of JM335 cells appeared frozen in all phases of the cell cycle with little progress from G(1) to S accompanied by a build-up of cells in G(2) indicative of a G(2)/M block. This difference in cell cycle effect may account for the reduced level of apoptosis at this concentration and a failure to engage apoptosis at higher concentrations. These data suggest that the nature of the platinum drug (and consequently, the nature of resultant DNA damage) may have important implications in determining the rate and mechanism of cell death in this cell line. The cell death effects observed with the trans complex JM335 may correlate with the induction of DNA single-strand breaks in this cell line.
引用
收藏
页码:1037 / 1045
页数:9
相关论文
共 38 条
[1]  
ARENDS MJ, 1990, AM J PATHOL, V136, P593
[2]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[3]   ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA [J].
BARRY, MA ;
BEHNKE, CA ;
EASTMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2353-2362
[4]  
BEALE P, 1996, P AM ASSOC CANC RES, V37, P210
[5]  
BROWN DG, 1993, J BIOL CHEM, V268, P3037
[7]   KEY MORPHOLOGICAL FEATURES OF APOPTOSIS MAY OCCUR IN THE ABSENCE OF INTERNUCLEOSOMAL DNA FRAGMENTATION [J].
COHEN, GM ;
SUN, XM ;
SNOWDEN, RT ;
DINSDALE, D ;
SKILLETER, DN .
BIOCHEMICAL JOURNAL, 1992, 286 :331-334
[8]   INTERNUCLEOSOMAL DNA CLEAVAGE SHOULD NOT BE THE SOLE CRITERION FOR IDENTIFYING APOPTOSIS [J].
COLLINS, RJ ;
HARMON, BV ;
GOBE, GC ;
KERR, JFR .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1992, 61 (04) :451-453
[9]   A BIOCHEMICAL HALLMARK OF APOPTOSIS - INTERNUCLEOSOMAL DEGRADATION OF THE GENOME [J].
COMPTON, MM .
CANCER AND METASTASIS REVIEWS, 1992, 11 (02) :105-119
[10]   DRUG-TARGET INTERACTIONS - ONLY THE 1ST STEP IN THE COMMITMENT TO A PROGRAMMED CELL-DEATH [J].
DIVE, C ;
HICKMAN, JA .
BRITISH JOURNAL OF CANCER, 1991, 64 (01) :192-196